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Optimization of Treatment 
Geometry to Reduce Normal Brain 
Dose in Radiosurgery of Multiple 
Brain Metastases with Single–
Isocenter Volumetric Modulated Arc 
Therapy
Qixue Wu, Karen Chin Snyder, Chang Liu, Yimei Huang, Bo Zhao, Indrin J. Chetty & Ning Wen
Treatment of patients with multiple brain metastases using a single-isocenter volumetric modulated 
arc therapy (VMAT) has been shown to decrease treatment time with the tradeoff of larger low dose to 
the normal brain tissue. We have developed an efficient Projection Summing Optimization Algorithm 
to optimize the treatment geometry in order to reduce dose to normal brain tissue for radiosurgery 
of multiple metastases with single-isocenter VMAT. The algorithm: (a) measures coordinates of outer 
boundary points of each lesion to be treated using the Eclipse Scripting Application Programming 
Interface, (b) determines the rotations of couch, collimator, and gantry using three matrices about 
the cardinal axes, (c) projects the outer boundary points of the lesion on to Beam Eye View projection 
plane, (d) optimizes couch and collimator angles by selecting the least total unblocked area for each 
specific treatment arc, and (e) generates a treatment plan with the optimized angles. The results 
showed significant reduction in the mean dose and low dose volume to normal brain, while maintaining 
the similar treatment plan qualities on the thirteen patients treated previously. The algorithm has 
the flexibility with regard to the beam arrangements and can be integrated in the treatment planning 
system for clinical application directly.
Surgery, chemotherapy, whole brain radiation therapy, and stereotactic radiosurgery (SRS) are common ther-
apeutic approaches to treat cranial metastases. With the improvement in high resolution imaging and patient 
treatment localization, SRS has a larger role in the treatment of multiple intracranial metastases1. SRS is most 
commonly delivered using a Gamma Knife unit or Linac based system2. Traditionally, Linac based SRS for mul-
tiple brain metastases utilizes a multiple isocenter approach, aligning each isocenter to the individual metastatic 
lesion and treating each lesion individually. This results in increased treatment time, where the treatment time 
increases proportionally to the number of lesions treated, due to patient re-positioning for each isocenter and the 
increased number of treatment beams.
Volumetric modulated arc therapy (VMAT) is a method of intensity modulated radiotherapy that can achieve 
conformal dose distributions by simultaneously varying the speed of the gantry rotation, the dose rate of the Linac, 
and the aperture shape of the multileaf collimator (MLC)3. Recently there has been significant interest in evaluat-
ing the viability of single isocenter Linac based VMAT for the treatment of multiple brain metastases4–6. Several 
studies have been performed comparing single isocenter VMAT to more traditional methods of treatment such 
as intensity modulated radiotherapy (IMRT), dynamic conformal arc (DCA), and 3D conformal radiotherapy7–10. 
These studies found that the plan quality of the single isocenter VMAT was equivalent or better than the other 
treatment techniques, and the treatment time decreased significantly. However, the low dose volume to normal 
brain increased significantly, up to 46% in some cases8. These studies led the authors to conclude that single 
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isocenter VMAT approach has significant high delivery efficiency without sacrificing plan quality, but with the 
disadvantage of increased low dose spillage to normal brain tissue. Studies have shown that the volume of normal 
brain tissue receiving low doses of radiation correlates with development of radiation necrosis after SRS11–14. Thus, 
the single isocenter VMAT plan quality needs further improvement by reducing the low dose spillage.
The increase in low dose spillage for the single isocenter VMAT plans has been proposed to be the result of the 
larger jaw openings allowing for increased leakage dose between the leaves9,10. A larger effect may be the result 
of the island blocking problem, as proposed by Kang J et al.15. The island blocking problem occurs when two or 
more targets share the same MLC leaf pair, resulting in an area of normal brain tissue that is not blocked by the 
MLCs as shown in Fig. 1. The purpose of this work was to develop an efficient optimization algorithm to reduce 
dose to normal brain tissue by optimizing treatment geometry in radiosurgery of multiple metastases with single 
isocenter VMAT.
Methods and Materials
We have developed a projection summing optimization algorithm to solve the island blocking problem. The 
algorithm includes (a) measuring coordinates of outer boundary points of each lesion using the Eclipse Scripting 
Application Programming Interface (ESAPI, Varian Medical Systems, Palo Alto, CA), (b) projecting the outer 
boundary points of the lesion on the BEV plane, (c) calculating the optimal couch and collimator angles with the 
least total open beam area on the BEV plane for each arc, and (d) generating treatment plans using the optimized 
angles.
Optimization of Treatment Geometry. Measurement of the coordinates of outer boundary points of 
lesions. To localize the lesions in the Beams Eye View (BEV), the coordinates of the boundary points of each 
lesion are measured using the ESAPI. The ESAPI is a programming interface and software library that allows 
software developers to write scripts to access the treatment planning information in Eclipse. The principle in 
measuring the outer boundary point coordinates is to find out the minimum and maximum values of the lesion 
location at each of the 3 orthogonal directions where the MLC leaves intersects transversally with lesion contours 
at each control point of an arc. Figure 2 demonstrates the six outer boundary points of a lesion (in red). The coor-
dinate system is identified with the DICOM coordinate system, where the X-axis is the right-left axis, the Y-axis 
is the anterior-posterior axis, and the Z-axis is the inferior-superior axis.
Rotations of couch/table, collimator, and gantry around the isocenter. The spatial rotations of the couch, collima-
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Figure 1. Anterior and posterior DRRs (upper) and MLC leaf pairs shared by two lesions (bottom) 
resulting in island blocking problems in the BEV projection planes indicated in red for a 3-lesion patient 
(left) and a 4-lesion patient (right). 
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where t, c, and g represent the couch, collimator, and gantry angles, respectively.
Projection of outer boundary point of lesion on to BEV projection plane. The rotations of the couch, collimator, 
and gantry are equivalent to rotations of the lesion(s). The new coordinates, R (new), of the lesions after the rota-
tion are obtained from the old coordinates, R (old), which were obtained from the ESAPI:
= · · ·R R(new) M(gantry) M (collimator) M(couch) (old) (4)
The order of product of three matrices, in this situation should be noted, since M (gantry) does not commute 
with M (couch) or M (collimator). The projected outer boundary coordinates in the XOZ plane was used to com-
pute the opening space area in the BEV projection plane at any given gantry angle.
Optimizing couch and collimator angles. For a given gantry angle, the projection of lesions on the BEV plane is 
schematically illustrated in Fig. 2. The red rectangle represents the opening space as calculated in the new coor-
dinate R (new). The total area unblocked by the MLCs is calculated by iteratively summing the unblocked area at 
each control point, approximately 2-degrees apart. The calculations are carried out for all feasible combinations of 
couch and collimator angles. The couch and collimator angles with the least total unblocked area are then selected 
as the optimized angles for that specific treatment arc. If the optimization came with multiple combinations 
of optimal couch and collimator angles, we defined the following selection criteria: (a) keeping treatment arcs 
equivalently spaced or symmetrical in order to reduce the low dose spread and the gradient index; (b) avoiding 
the collision between the couch and gantry.
The feasible angles of the collimator ranged from 0- to 165-degrees, due to the limitation of the collimator 
rotation on the machine. Since the leaves are symmetric, angles 165–360 were not included. The range of the 
couch angles was determined in order to avoid collisions between the couch and gantry. The possible range of 
couch angles was selected as follows:
− < = <
Arc (degree) Couch (degree)
181 clockwise 179 or 179 counter clockwise 181 15 t 15 (5)
< = <179 counter clockwise 350 or 350 clockwise 179 15 t 90 (6)
− < = < −10 counter clockwise 181 or 181 clockwise 10 90 t 15 (7)
3 to 4 partial or full arcs were used in the treatment plans. The corresponding couch and collimator angles were 
optimized with 5-degree intervals for each arc. Plans generated with the optimized couch and collimator angles 
were compared to plans generated with the same couch angles and a fixed collimator angle of 45 degree used by 
Wolff5, Kang15, and Audet16 in order to evaluate the reduction in low dose spillage to normal brain tissue with 
optimized angles.
Patient and Plan Characteristics. A retrospective study of thirteen patients previously treated with 3–5 
brain lesions was conducted as part of a protocol approved by the Henry Ford Hospital Institutional Review 
Board. Table 1 summarizes the number and volume of the lesions for each patient. The average volume of the 
planning target volume (PTV) was 1.00 cc (range 0.02–6.88 cc). The PTV of all the lesions was combined into a 
PTVtotal for plan evaluation. The PTVtotal for each patient ranged from 0.47 to 11.37 cc.
Plans were generated in the Eclipse treatment planning system. The progressive resolution optimizer 
(V13.5.35) was used for VMAT optimization and the anisotropic analytical algorithm (AAA, V13.5.35) with 
Figure 2. Schematic illustrations of measured coordinate values in mm of two outer boundary points of a 
lesion in blue in the X direction(left), and the projection of two lesions from the BEV (right). The two black 
ellipsoids are the two lesions, the blue lines represent the MLC leafs, and the red rectangle represents the area 
unblocked by the MLCs calculated in the new coordinate R (new).
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a grid size of 1mm was used for final dose calculation. A 6MV high intensity flattening filter free (FFF) pho-
ton beam with a maximum dose rate of 1400 MU/min was utilized. Plans were optimized following the single 
isocenter VMAT planning guideline published by Clark et al.6. All plans were normalized so that greater than 99% 
of the PTVtotal received the prescription dose of 18 Gy.
The isocenter was placed at the geometric center of the PTVtotal. The parameters used to evaluate the dose to 
the normal brain tissue included the volume of normal brain that received 4, 6, 8, 10, and 12 Gy (V4, V6, V8, V10, 
and V12, respectively), as well as the mean dose to the normal brain tissue. Plan quality amongst the plans were 
evaluated using the conformity index (CI), defined as the ratio of the volume of the prescription dose over the 
volume of each individual PTV; the homogeneity index (HI), defined as the ratio of the maximum dose over the 
prescription dose; and the gradient index (GI), defined as the ratio of the volume of 50% of the prescription dose 
over the volume of 100% of the prescription.
Results
Thirteen patients with 3 to 5 brain metastatic lesions were studied in this work. The optimized couch and collimator 
angles of each arc were obtained from the Projection Summing Optimizing Algorithm and used to generate treat-
ment plans for each patient. For instance, Table 2 lists the values of optimized angles of couch and collimator for 
patient 1 with three lesions. According to the selection criteria described previously, these couch and collimator 
angles were chosen for each of the three arcs: (0°, 10°); (45°, 5°) and (315°, 5°). Figure 3 shows the comparison of 
dose distributions of two plans with and without optimized couch and collimator angles for this patient. Better 
dose conformity was achieved in the plan with optimized couch and collimator angles. Quantitatively, 69%, 60%, 
32%, 26%, 21%, and 35% reductions were obtained respectively in the V4, V6, V8, V10, V12, and mean dose of 
normal brain using optimized angles. Figure 4 displays the DVH curves of the lesions and normal brain of the 
three plans: without optimization, and optimized for the least and most open space area unblocked by the MLCs. 
The optimized plan with the maximum opening space area was generated to demonstrate the worst case scenario.
Table 3 shows the percent reduction of dose volume, mean dose of normal brain, and mean dosimetric indices 
CI, HI, and GI of all lesions with and without optimal couch and collimator angles. The mean ± standard error of 
the percent reduction of the V4, V6, V8, V10, V12 and mean dose of the normal brain was 17.6 ± 5.1 (p = 0.0003), 
13.7 ± 4.7 (p = 0.0005), 6.8 ± 2.5 (p = 0.003), 4.2 ± 2.1 (p = 0.004), 3.1 ± 1.6 (p = 0.00005), and 8.4 ± 2.9 
(p = 0.006), respectively if optimal collimator and couch angles were used in the treatment plans. The dose vol-
ume of normal brain tissue and mean dose of normal brain were reduced significantly due to using the opti-
mal couch and collimator angles. The mean ± standard error of the CI, HI and GI were 1.24 ± 0.04/1.25 ± 0.04 
(p = 0.245), 1.16 ± 0.02/1.16 ± 0.02 (p = 0.111), and 5.24 ± 0.52/5.26 ± 0.51 (p = 0.668) with and without opti-
mization. They were no significant changes to the plan quality after optimizing couch and collimator angles. The 
plan quality was maintained after the optimization with slight improvement, indeed.
Patient number No. of lesions Volume of each lesion (cc) PTVtotal (cc)
1 3 0.46 0.04 0.02 0.52
2 3 0.12 0.16 0.19 0.47
3 4 0.33 0.51 0.36 1.16 2.36
4 4 0.33 0.38 0.68 0.12 1.51
5 4 2.63 1.57 1.83 0.76 6.79
6 4 0.15 0.17 0.75 0.42 1.49
7 5 0.31 0.25 0.42 0.75 0.29 2.02
8 5 0.23 1.16 0.25 2.73 0.22 4.59
9 5 0.31 0.09 0.39 1.27 0.50 2.56
10 5 0.84 1.81 1.42 1.06 0.77 5.90
11 3 1.15 2.21 1.48 4.84
12 4 4.05 4.06 0.11 0.39 8.61
13 4 6.88 2.24 1.65 0.60 11.37
Table 1. Patient characteristics.
Arc1: Gantry: 181–179 
Clockwise
Arc2: Gantry 179–350 
Counter Clockwise
Arc3: Gantry 10–181 
Counter Clockwise
Couch Collimator Couch Collimator Couch Collimator
350 15 35 40 275 25
0 10 40 10 280 10
5 20 45 5 295 40
10 40 50 100 315 5
55 140 325 55
Table 2. Optimized couch and collimator angles for each arc of patient 1 (degree).
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We also evaluated the dependence of the reduction of dose volume of normal brain on the number of lesions. 
Figure 5 illustrates the percent reduction of dose volumes by averaging all the plans with the same number of 
lesions. Significant dose volume reduction was achieved on the three plans with three lesions. The benefit of opti-
mization was diminished as the number of lesions increased.
Discussion
Gamma Knife has been the predominant modality used for confocal treatment of multiple metastases. Linac 
based SRS treatment becomes attractive because its sub-millimeter targeting accuracy17, high delivery efficiency18 
and excellent plan quality6. Previous work has found Gamma Knife to be superior to conformal arc-based mul-
tiple target SRS with regard to normal brain exposure19, the new generation of Linacs are equipped with a high 
definition MLC, flattening filter free photon beams (sharper penumbra), jaw tracking and VMAT delivery (less 
low dose spill to normal brain). Evan M.T. et al.1 compared the plan quality and delivery time between VMAT and 
Gamma Knife radiosurgery for multiple cranial metastases. Compared to Gamma knife, VMAT produced clin-
ically equivalent conformity, dose falloff, low isodose spill, and reduced treatment time for multiple lesion treat-
ment. Daniel M et al.20 compared radiation dose spillage from the Gamma Knife Perfexion with that from VMAT 
during treatment of multiple brain metastases. They found that VMAT plans had more dose to the normal brain 
tissues than plans for Gamma Knife20. However, wider-width MLC was used in their study, which could be a lim-
iting factor to produce high quality plans for small lesions. Instead, in Evan’s study1, a high definition MLC with 
2.5 mm leaf width was used and led to better plan conformality and lower dose spillage. Single isocenter VMAT 
to treat multiple targets has a higher efficiency, but the island blocking problem could lead to an increased low 
dose spillage to normal brain. This island blocking problem could be solved by optimizing the treatment geom-
etry. The pioneer work was done by Kang et al. to optimize the treatment geometry in single-isocenter VMAT15. 
They computed the overlapping sonogram of two lesions to seek the optimized angles of couch and collimator. 
Figure 3. Isodose distributions of two plans for patient 1 with 3 lesions: Left-without optimizing angles 
of couch and collimator; Right-with optimizing angles of couch and collimator. Dose levels: Purple-4 Gy, 
Yellow-8 Gy, Blue-10 Gy, Cyan-18 Gy.
www.nature.com/scientificreports/
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Figure 4. DVHs of the 3 plans. Two with optimized angles selected from minimum beam aperture space 
(Black - W/OPT MIN) and selected from maximum beam aperture space (green - W/OPT MAX). The third 
plan without optimized angles (red - W/O OPT). Similar coverage of each lesion is also illustrated within the 
three plans.
Patient 
number V4 V6 V8 V10 V12
Mean 
dose CI HI GI
1 69.4 60.6 32.7 26.7 21.3 35.5 1.04/1.09 1.18/1.21 6.42/6.30
2 21.2 21.1 5.5 4.0 5.0 9.6 1.58/1.65 1.11/1.12 3.67/3.47
3 12.5 4.7 3.0 0.9 0.5 1.1 1.12/1.12 1.10/1.10 7.20/7.28
4 21.6 13.5 4.1 2.6 1.3 4.7 1.24/1.25 1.12/1.13 5.22/5.18
5 10.3 6.9 4.8 2.3 1.2 3.2 1.12/1.10 1.12/1.12 2.82/2.77
6 8.4 4.9 2.1 0.5 1.7 1.9 1.27/1.28 1.09/1.09 4.39/4.29
7 9.0 4.5 2.0 1.0 2.0 5.4 1.31/1.34 1.11/1.11 5.98/6.07
8 11.3 14.3 10.5 4.7 1.6 3.6 1.26/1.28 1.11/1.12 6.68/6.56
9 2.9 2.2 1.2 0.7 1.1 4.5 1.23/1.28 1.12/1.12 7.03/7.01
10 5.3 7.5 1.3 2.1 0.9 0.8 1.16/1.17 1.14/1.14 8.02/7.92
11 27.0 22.0 6.1 2.1 1.2 18.1 1.23/1.26 1.27/1.27 4.08/4.02
12 20.1 12.9 10.9 5.9 1.0 15.5 1.37/1.31 1.31/1.32 3.70/4.08
13 10.1 3.1 4.1 1.1 1.0 5.9 1.16/1.12 1.29/1.28 3.20/3.23
Table 3. Percent reduction of dose volume, mean dose of normal brain, and mean dosimetric indices CI, 
HI, and GI of lesions with/without optimizing angles of couch and collimator.
Figure 5. The average percent reduction of the V4, V6, V8, V10 and V12 of normal brain in the three plans 
with three lesions, six plans with four lesions and four plans with five lesions. 
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Our Projection Summing Optimization Algorithm calculated the unblocked area directly by projecting the outer 
boundary points of the lesions in the BEV projection planes. The algorithm has the flexibility with regard to 
the beam arrangements and can be integrated in the treatment planning system for clinical application directly. 
Compared to plans using the conventional treatment geometry, the plans generated with optimized couch and 
collimator angles showed significant reduction in the mean dose and low dose volume to normal brain. The plan 
quality using VMAT approach can be further enhanced by implementing the Projection Summing Optimization 
Algorithm.
The reduction of normal brain dose depends on many factors such as the number of lesions, the size of each 
lesion, and the relative location and amount of overlap of lesions in the BEVs for the specific patient. Our study 
focused on the optimization of single isocenter VMAT plans for patients with three to five brain metastases con-
sidering multiple randomized controlled trials have been carried out using SRS for patients with one to four brain 
metastases21. Patients with more than five lesions have been treated with the whole-brain radiation therapy in our 
institute to cover other undetected metastases and protect against intracranial relapse. As claimed by Jairam V 
et al., the current evidence of the efficacy of SRS-only treatment with more than four brain metastases was still 
sparse and limited to retrospective study21. We found that in average, the dose volume reduction to normal brain 
decreased as the number of lesions increased after the optimization of treatment geometry. Even though the 
island blocking problem could become more problematic as the number of lesions increases, the benefit of dose 
volume reduction on the normal brain was reduced by optimizing the couch and collimator angles. The tumor 
volumes studied in this work were relatively small. The reason is that our SRS program typically treats patients 
with intracranial lesions that are small or that have a minimal mass effect. The local control of larger tumors with 
SRS could be compromised since the prescription dose has to be limited to reduce integral dose to the normal 
brain. The blocking space would increase as the size of tumor increased. The optimization could minimize the 
blocking spaces effectively and reduce the normal brain dose correspondingly. A study on a larger cohort of 
patients is still needed to further investigate the correlation of multiple factors on the dose reduction in normal 
brain.
This study was limited by not showing follow-up MR imaging to demonstrate the effectiveness of reducing 
radionecrosis using the algorithm. In order to evaluate the performance and safety of the algorithm before apply-
ing it to the patient care directly, we applied the optimization algorithm to the patients treated previously and 
compared the plan quality with and without the optimization. However, it has been demonstrated in many studies 
that dose volume data during SRS correlates with the development of postradiosurgical imaging changes sug-
gestive of radiation necrosis. The Karolinska group developed a model to predict the risk for radiation induced 
complications following Gamma Knife radiosurgery for 1128 AVM patients22. They concluded that the risk of 
complications was dependent on the dose distribution, clinical history, AVM location. Flickinger et al. at the 
University of Pittsburgh studied the toxicity of 307 AVM patients treated with Gamma knife with post treat-
ment MRI follow-up. 30% of patients had postradiosurgical imaging changes23. Multivariate analysis showed that 
symptomatic postradiosurgical imaging changes correlated significantly with12 Gy volume23. However, most of 
these studies were published decades ago and focused on the AVM patients treated with Gamma knife radio-
surgery. Voges et al. correlated the risk of symptomatic radiation necrosis to 10 Gy volume for AVM patients 
treated with Linac based SRS24. In a recent study at the University of Cincinnati, a single institution retrospective 
analysis was performed for a total of 125 patients with 345 intracranial metastases received Linac based SRS 
treatment12. Radionecrosis was diagnosed based on follow-up MR imaging and histologic evidence. Multivariate 
regression analysis showed that 8 through 12 Gy volume were the most predictive factors for both symptomatic 
and asymptomatic radionecrosis in Linac based single fraction SRS of brain metastases12. Other factors such as 
plan conformality and dose inhomogeneity have also been investigated in many studies too. Neither conformality 
nor dose inhomogeneity were found to correlate with post radiosurgical symptomatic imaging changes12,13,23,25. 
Therefore, we think dose volume data of normal brain in the SRS is probably one of the best predictors of radi-
onecrosis. We have demonstrated that by implementing our optimization algorithm, the dose to the normal brain 
could be reduced effectively. It would significantly reduce the risk of radionecrosis. Our next step is to enroll 
patients in a clinical trial with follow-up MR imaging to demonstrate the clinical benefits of the optimization 
algorithm.
Conclusions
A projection Summing Optimization Algorithm was developed to address the island blocking problem and has 
showed great improvement in reducing the low dose to normal brain tissue, while the similar dose coverage 
to the lesions was maintained. The algorithm can be a robust option to planners to select optimal couch and 
collimator angles for reducing normal brain dose. The results of the present study suggest that we can achieve a 
significant dosimetric advantage using this algorithm in single-isocenter VMAT to treat patients with multiple 
brain metastases.
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